242 related articles for article (PubMed ID: 27230839)
1. [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].
Nagano N; Tsutsui T
Clin Calcium; 2016 Jun; 26(6):839-50. PubMed ID: 27230839
[TBL] [Abstract][Full Text] [Related]
2. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators.
Breitwieser GE
Pharmacol Res; 2014 May; 83():30-7. PubMed ID: 24291533
[TBL] [Abstract][Full Text] [Related]
5. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
6. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulators of the extracellular calcium receptor.
Nemeth EF
Drug Discov Today Technol; 2013; 10(2):e277-84. PubMed ID: 24050279
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR).
Brown EM
Biochem Pharmacol; 2010 Aug; 80(3):297-307. PubMed ID: 20382129
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.
Nagano N
Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839
[TBL] [Abstract][Full Text] [Related]
10. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
Leach K; Wen A; Cook AE; Sexton PM; Conigrave AD; Christopoulos A
Endocrinology; 2013 Mar; 154(3):1105-16. PubMed ID: 23372019
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.
Avlani VA; Ma W; Mun HC; Leach K; Delbridge L; Christopoulos A; Conigrave AD
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1097-104. PubMed ID: 23531616
[TBL] [Abstract][Full Text] [Related]
12. Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control.
Massy ZA; Hénaut L; Larsson TE; Vervloet MG
Semin Nephrol; 2014 Nov; 34(6):648-59. PubMed ID: 25498383
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the calcium sensing receptor.
Filopanti M; Corbetta S; Barbieri AM; Spada A
Clin Cases Miner Bone Metab; 2013 Sep; 10(3):162-5. PubMed ID: 24554924
[TBL] [Abstract][Full Text] [Related]
14. Sensing Extracellular Calcium - An Insight into the Structure and Function of the Calcium-Sensing Receptor (CaSR).
Chavez-Abiega S; Mos I; Centeno PP; Elajnaf T; Schlattl W; Ward DT; Goedhart J; Kallay E
Adv Exp Med Biol; 2020; 1131():1031-1063. PubMed ID: 31646544
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Development of Calcimimetic and Calcilytic Compounds.
Nemeth EF; Van Wagenen BC; Balandrin MF
Prog Med Chem; 2018; 57(1):1-86. PubMed ID: 29680147
[TBL] [Abstract][Full Text] [Related]
17. [Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].
Nagano N
Clin Calcium; 2005 Jan; 15(1):71-8. PubMed ID: 15632475
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.
Makita N; Ando T; Sato J; Manaka K; Mitani K; Kikuchi Y; Niwa T; Ootaki M; Takeba Y; Matsumoto N; Kawakami A; Ogawa T; Nangaku M; Iiri T
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996138
[TBL] [Abstract][Full Text] [Related]
19. Novel strategies in drug discovery of the calcium-sensing receptor based on biased signaling.
Thomsen AR; Smajilovic S; Bräuner-Osborne H
Curr Drug Targets; 2012 Sep; 13(10):1324-35. PubMed ID: 22702634
[TBL] [Abstract][Full Text] [Related]
20. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain.
Petrel C; Kessler A; Dauban P; Dodd RH; Rognan D; Ruat M
J Biol Chem; 2004 Apr; 279(18):18990-7. PubMed ID: 14976203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
